Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VORASIDENIB vs VORTIOXETINE HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VORASIDENIB vs VORTIOXETINE HYDROBROMIDE: Safety Overview

Metric VORASIDENIB VORTIOXETINE HYDROBROMIDE
Total FAERS Reports 264 13,705
Deaths Reported 6 400
Death Rate 2.3% 2.9%
Hospitalizations 57 1,741
Average Patient Age 43.6 yrs 48.8 yrs
% Female Patients 11.1% 69.5%
FDA Approval Date Aug 6, 2024 Sep 30, 2013
Manufacturer Servier Pharmaceuticals LLC Takeda Pharmaceuticals America, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription